paperKB
coga / coga-kb
Help
Sign in

Chunk #9 — Neurobiology of nicotine — Neurotransmitter pathways and nicotine dependence

Source
Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes.
Embedded
yes

Text

of the ventral tegmental area (VTA), resulting in dopamine release in the nucleus accumbens and contributing to the rewarding and motivational effects of nicotine (Corrigall et al. 1994; Laviolette and van der Kooy 2004; Mineur and Picciotto 2008; Nisell et al. 1994). Further, molecular alterations in central dopamine systems contribute to craving and modulate the aversive effects of nicotine withdrawal (Changeux 2010; Laviolette and van der Kooy 2004; Mansvelder et al. 2002; Mansvelder and McGehee 2002). While a single cigarette smoked in the morning can saturate and desensitize roughly 80–90% of nAChRs for several hours, smokers may continue to smoke throughout the day to avoid having free unbound receptors (Brody et al. 2006). The free, non-desensitized receptors may be responsible for cravings and continued smoking acts on these receptors to provide positive reinforcement and sustained dopamine release to prevent withdrawal symptoms (Balfour 2004; Brody et al. 2006).